Loading
Tampa-based Oragenics, a high-tech pharmaceutical company, says its CEO stepped down as of Monday.
In a Monday evening news release, Oragenics says former CEO Kimberly Murphy entered into a mutual separation agreement. Murphy will stay on the company board, officials say.Â
The board appointed Michael Redmond, company president, as interim "principal executive officer."
Subscribe today. Cancel anytime.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
